These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 33082558)
1. MITF is a driver oncogene and potential therapeutic target in kidney angiomyolipoma tumors through transcriptional regulation of CYR61. Zarei M; Giannikou K; Du H; Liu HJ; Duarte M; Johnson S; Nassar AH; Widlund HR; Henske EP; Long HW; Kwiatkowski DJ Oncogene; 2021 Jan; 40(1):112-126. PubMed ID: 33082558 [TBL] [Abstract][Full Text] [Related]
2. Urokinase-type plasminogen activator (uPA) is critical for progression of tuberous sclerosis complex 2 (TSC2)-deficient tumors. Stepanova V; Dergilev KV; Holman KR; Parfyonova YV; Tsokolaeva ZI; Teter M; Atochina-Vasserman EN; Volgina A; Zaitsev SV; Lewis SP; Zabozlaev FG; Obraztsova K; Krymskaya VP; Cines DB J Biol Chem; 2017 Dec; 292(50):20528-20543. PubMed ID: 28972182 [TBL] [Abstract][Full Text] [Related]
3. Whole Exome Sequencing Identifies TSC1/TSC2 Biallelic Loss as the Primary and Sufficient Driver Event for Renal Angiomyolipoma Development. Giannikou K; Malinowska IA; Pugh TJ; Yan R; Tseng YY; Oh C; Kim J; Tyburczy ME; Chekaluk Y; Liu Y; Alesi N; Finlay GA; Wu CL; Signoretti S; Meyerson M; Getz G; Boehm JS; Henske EP; Kwiatkowski DJ PLoS Genet; 2016 Aug; 12(8):e1006242. PubMed ID: 27494029 [TBL] [Abstract][Full Text] [Related]
4. ATF3 inhibits the tumorigenesis and progression of hepatocellular carcinoma cells via upregulation of CYR61 expression. Chen C; Ge C; Liu Z; Li L; Zhao F; Tian H; Chen T; Li H; Yao M; Li J J Exp Clin Cancer Res; 2018 Oct; 37(1):263. PubMed ID: 30376856 [TBL] [Abstract][Full Text] [Related]
5. Therapeutic Targeting of the Secreted Lysophospholipase D Autotaxin Suppresses Tuberous Sclerosis Complex-Associated Tumorigenesis. Feng Y; Mischler WJ; Gurung AC; Kavanagh TR; Androsov G; Sadow PM; Herbert ZT; Priolo C Cancer Res; 2020 Jul; 80(13):2751-2763. PubMed ID: 32393662 [TBL] [Abstract][Full Text] [Related]
6. Genotype-phenotype correlation of patients with tuberous sclerosis complex-associated renal angiomyolipoma: a descriptive study. Li S; Zhang Y; Wang Z; Yang Y; Gao W; Li D; Wei J Hum Pathol; 2018 Dec; 82():61-67. PubMed ID: 30036593 [TBL] [Abstract][Full Text] [Related]
7. Angiomyolipoma have common mutations in TSC2 but no other common genetic events. Qin W; Bajaj V; Malinowska I; Lu X; MacConaill L; Wu CL; Kwiatkowski DJ PLoS One; 2011; 6(9):e24919. PubMed ID: 21949787 [TBL] [Abstract][Full Text] [Related]
8. Renal disease in adults with TSC2/PKD1 contiguous gene syndrome. Martignoni G; Bonetti F; Pea M; Tardanico R; Brunelli M; Eble JN Am J Surg Pathol; 2002 Feb; 26(2):198-205. PubMed ID: 11812941 [TBL] [Abstract][Full Text] [Related]
9. Rapamycin-insensitive up-regulation of adipocyte phospholipase A2 in tuberous sclerosis and lymphangioleiomyomatosis. Li C; Zhang E; Sun Y; Lee PS; Zhan Y; Guo Y; Osorio JC; Rosas IO; Xu KF; Kwiatkowski DJ; Yu JJ PLoS One; 2014; 9(10):e104809. PubMed ID: 25347447 [TBL] [Abstract][Full Text] [Related]
10. Clinical and Molecular Characterization of Microphthalmia-associated Transcription Factor (MITF)-related Renal Cell Carcinoma. Lang M; Vocke CD; Ricketts CJ; Metwalli AR; Ball MW; Schmidt LS; Linehan WM Urology; 2021 Mar; 149():89-97. PubMed ID: 33242557 [TBL] [Abstract][Full Text] [Related]
11. Construction of TSC2 knockout cell line using CRISPR/Cas9 system and demonstration of its effects on NIH-3T3 cells. Wang X; Zhao Y; Wang Z; Liao Z; Zhang Y Cell Biochem Biophys; 2022 Dec; 80(4):681-687. PubMed ID: 36181622 [TBL] [Abstract][Full Text] [Related]
12. Carcinomalike monotypic epithelioid angiomyolipoma in patients without evidence of tuberous sclerosis: a clinicopathologic and genetic study. Martignoni G; Pea M; Bonetti F; Zamboni G; Carbonara C; Longa L; Zancanaro C; Maran M; Brisigotti M; Mariuzzi GM Am J Surg Pathol; 1998 Jun; 22(6):663-72. PubMed ID: 9630173 [TBL] [Abstract][Full Text] [Related]
13. Gene expression profiling identifies microphthalmia-associated transcription factor (MITF) and Dickkopf-1 (DKK1) as regulators of microenvironment-driven alterations in melanoma phenotype. Hartman ML; Talar B; Noman MZ; Gajos-Michniewicz A; Chouaib S; Czyz M PLoS One; 2014; 9(4):e95157. PubMed ID: 24733089 [TBL] [Abstract][Full Text] [Related]
14. Activation of the mTOR pathway in sporadic angiomyolipomas and other perivascular epithelioid cell neoplasms. Kenerson H; Folpe AL; Takayama TK; Yeung RS Hum Pathol; 2007 Sep; 38(9):1361-71. PubMed ID: 17521703 [TBL] [Abstract][Full Text] [Related]
15. Melanoma markers in angiomyolipoma of the liver and kidney: a comparative study. Makhlouf HR; Ishak KG; Shekar R; Sesterhenn IA; Young DY; Fanburg-Smith JC Arch Pathol Lab Med; 2002 Jan; 126(1):49-55. PubMed ID: 11800647 [TBL] [Abstract][Full Text] [Related]
16. GLI2 and M-MITF transcription factors control exclusive gene expression programs and inversely regulate invasion in human melanoma cells. Javelaud D; Alexaki VI; Pierrat MJ; Hoek KS; Dennler S; Van Kempen L; Bertolotto C; Ballotti R; Saule S; Delmas V; Mauviel A Pigment Cell Melanoma Res; 2011 Oct; 24(5):932-43. PubMed ID: 21801332 [TBL] [Abstract][Full Text] [Related]
17. Malignant tumors of the kidney, brain, and soft tissues in children and young adults with the tuberous sclerosis complex. Al-Saleem T; Wessner LL; Scheithauer BW; Patterson K; Roach ES; Dreyer SJ; Fujikawa K; Bjornsson J; Bernstein J; Henske EP Cancer; 1998 Nov; 83(10):2208-16. PubMed ID: 9827727 [TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical and reverse transcription-polymerase chain reaction expression analysis of tyrosinase and microphthalmia-associated transcription factor in angiomyolipomas. Jungbluth AA; King R; Fisher DE; Iversen K; Coplan K; Kolb D; Williamson B; Chen YT; Stockert E; Old LJ; Busam KJ Appl Immunohistochem Mol Morphol; 2001 Mar; 9(1):29-34. PubMed ID: 11277411 [TBL] [Abstract][Full Text] [Related]
19. SOX5 is involved in balanced MITF regulation in human melanoma cells. Kordaß T; Weber CE; Oswald M; Ast V; Bernhardt M; Novak D; Utikal J; Eichmüller SB; König R BMC Med Genomics; 2016 Feb; 9():10. PubMed ID: 26927636 [TBL] [Abstract][Full Text] [Related]
20. The Codon 72 Cho JH; Patel B; Bonala S; Mansouri H; Manne S; Vadrevu SK; Ghouse S; Kung CP; Murphy ME; Astrinidis A; Henske EP; Kwiatkowski DJ; Markiewski MM; Karbowniczek M Mol Cancer Res; 2019 Aug; 17(8):1639-1651. PubMed ID: 31088907 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]